If you are an active scientific researcher in the gene therapy arena, we would like to invite you to contribute to this new open resource. It is our aim to build a content-rich site that can be browsed by anyone wanting to expand their understanding of the development and application of novel genetic therapeutics. We ask you to submit a short description of the work that you and your laboratory currently undertake in gene therapy. This will then be listed in the relevant research directory that constitutes part of the site. Alternatively, if you are a clinician or patient currently involved in a gene therapy trial we are interested to hear your experiences or suggestions.
Describing Your Research
Submissions should be no more than two pages of size A4 (single- spaced) and can include up to five figures. Descriptions can relate to your institute/lab and your research. Manuscripts should be written bearing in mind the reader will view it in the context of a web page (but will be able to print or download as a pdf file also). In your description you can also include links to any location in your institute's site. Links throughout the submitted text should be described in bold with the web address in parentheses immediately after. You are also invited to cite five of your most recent publications and the links to the full text articles from the journal's website, or to the abstract on Entrez Pubmed. As a contributor, you also have the option of having a small biography with your contact details and research experiences published on the Gene Therapy Review. Moreover, if you wish, you can also create a user account giving you editorial privileges over the content that you submit. Please indicate whether you would like us to include your contact details on our site and whether you would like to create a user account with editorial privileges.
If you are interested in having editorial control over your submissions, then please register with the Gene Therapy Review online and send your user name with your contribution to our editorial offices at editorial@genetherapyreview.com. The Gene Therapy Review also maintains a clinical trial database listing all past and present clinical trials utilizing gene transfer or cellular therapy as their mode of action. If you run a gene therapy trial and it is not listed in our database then please contact the gene therapy review with the details of the trial. Finally, the Gene Therapy Review is designed as an open access, content rich web portal containing information on all aspects of gene therapy. Users are invited to submit content describing their expertise or experiences in the gene therapy field. With this in mind, we would be grateful if you could promote the site by including a link to us on your webpage:
http://www.genetherapyreview.com : An open-access resource containing information on all aspects of gene therapy.
Mini-Review Articles
These articles should be aimed at the undergraduate level, or with a view to inform non-experts in the field about various aspects of gene therapy. Examples of educational articles may include (but are not restricted to) description of gene transfer vectors or systems, descriptions of manufacturing processes, descriptions of diseases or disease models that are employed in their study, methods of stem cell isolation/modifications etc. Submissions should be no more than five pages of size A4 (single- spaced) and can include up to five figures. Manuscripts should be written bearing in mind the reader will view it in the context of a web page (but will be able to print or download as a pdf file also). In your description you can also include links to any website that you deem to contain relevant information. Links throughout the submitted text should be described in bold with the web address in parentheses immediately after. Scientific articles can be referenced in your text by a number and the full reference should follow the format below and placed at the end of the text under the heading ‘References’. For Example:
6. Du, B, et al. (1996). Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther 3:254-61. PMID: 8646557
If more than three authors have written the article, please use the format outlayed above, for articles with two or three authors please list all authors.
The corresponding numeral of the article in the main body of the text will link directly to the abstract on the Pubmed website. Therefore, authors should also supply the Pubmed ID for each citation immediately after each reference.
Technical Reviews
Additionally, contributors may want to comment on the current status of a technology (e.g. lentiviral vectors), or a field (e.g. an update on all clinical trials involving Cystic Fibrosis patients). These contributions should be more technical in nature than educational articles and should be written to describe the latest advances. Contributions taking this format will be published in the technology review section of the site and should take the same form as educational articles (e.g. five single- spaced A4 pages with up to five figures and with references in the same format). Upon submission you should indicate whether you want your contribution should appear as a technical review, or an educational article.
Your name and biography will be included in every review article and technology overview that you contribute.
These instructions can be downloaded as a pdf file. For more information contact editorial@genetherapyreview.com |
Submit Article 
